亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Imprinted Polymer Nanoparticles

技術優勢
-Cost: Synthetic antibodies are polymer-based, which are cheaper, easier to handle and purify, and have a longer shelf life than biologically-derived materials -Safety: Synthetic treatments are at a lower risk of having biological contamination because they are not sourced from viral or bacterial pathogens
技術應用
-Protein or peptide purification -Toxin removal -Replacement of monoclonal antibodies as therapeutics
詳細技術說明
Researchers at UC Irvine developed a method to imprint polymer nanoparticles (NPs) that are composed of vinyl, acryl, and/or methacryl monomers. NPs are cross-linked in the presence of the target molecule (e.g., peptide), leaving behind an “imprint” of said molecule on the NPs. As a result, these synthetic or “plastic” antibodies have a high affinity for the target molecule and can specifically bind it in solution. These polymers can be used in biomoacromolecular purification (e.g., to purify n antibodies or hormones), in toxin removal (e.g., hemoperfusion), in diagnostics, as well as in therapeutic methods (e.g., therapeutic methods where antisera or monoclonal antibodies are normally employed).
*Abstract

Synthetic polymer nanoparticles (NPs) capable of recognizing specific biomacromolecules and can be used as substitutes for natural antibodies .

*IP Issue Date
Nov 3, 2015
*Principal Investigation

Name: Yu Hoshino

Department:


Name: Kenneth Shea

Department:

申請號碼
9173943
其他

Tech ID/UC Case

24659/2007-533-0


Related Cases

2007-533-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備